World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
47
Citations
10518
World Ranking
18612
National Ranking
7610

Overview

Katharine C. Hsu is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple facets of immunology, medicine, and hematology, with significant contributions in oncology, epidemiology, and cell biology.

The primary fields of study for Katharine C. Hsu include:

  • Immunology and Microbiology
  • Medicine

Subfields of study present in their work include:

  • Immunology
  • Hematology
  • Oncology
  • Epidemiology
  • Cell Biology

The main research topics covered by Katharine C. Hsu's publications are:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • CAR-T Cell Therapy Research
  • Cytomegalovirus and Herpesvirus Research
  • Immunotherapy and Immune Responses
  • Cellular Mechanics and Interactions

Frequent publication venues where they have contributed are:

  • Blood Advances
  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Transplantation and Cellular Therapy
  • Cancer Research

Notable recent papers by Katharine C. Hsu include:

  • "Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer," 2021, Immunity
  • "HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation," 2020, Blood
  • "Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity," 2021, Science Immunology
  • "Deconvoluting global cytokine signaling networks in natural killer cells," 2021, Nature Immunology
  • "High progression-free survival after intermediate intensity double unit cord blood transplantation in adults," 2020, Blood Advances

Frequent co-authors collaborating with Katharine C. Hsu include:

  • Jean-Benoît Le Luduec
  • Brian C. Shaffer
  • M. Kazim Panjwani
  • Joseph C. Sun
  • Rosa Sottile

Best Publications

  • Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

    Steven G. E. Marsh;Peter Parham;Bo Dupont;Daniel E. Geraghty

  • Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

    R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd

  • Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

    Katharine C. Hsu;Carolyn A. Keever-Taylor;Carolyn A. Keever-Taylor;Carolyn A. Keever-Taylor;Andrew Wilton;Andrew Wilton;Andrew Wilton;Clara Pinto;Clara Pinto;Clara Pinto

  • The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

    Katharine C. Hsu;Shohei Chida;Daniel E. Geraghty;Bo Dupont

  • Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets

    Katharine C. Hsu;Xiao-Rong Liu;Annamalai Selvakumar;Eric Mickelson

  • HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1

    Jeffrey M. Venstrom;Gianfranco Pittari;Ted A. Gooley;Joseph H. Chewning

  • HLA alleles determine differences in human natural killer cell responsiveness and potency.

    Sung Jin Kim;John B. Sunwoo;Liping Yang;Taewoong Choi

  • Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002: Marsh et al : KIR nomenclature report, 2002

    S.G.E. Marsh;P. Parham;B. Dupont;D.E. Geraghty

  • TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

    Sandra Kesh;Nana Yaa Mensah;Paolo Peterlongo;Dana Jaffe

  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

    Nidale Tarek;Jean Benoit Le Luduec;Meighan M. Gallagher;Junting Zheng

  • Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

    Junli Yu;Glenn Heller;Joseph Chewning;Sung Jin Kim

  • KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy

    Katharine C. Hsu;Ted Gooley;Mari Malkki;Clara Pinto-Agnello

  • Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

    Jumei Shi;Guido Tricot;Susann Szmania;Nancy Rosen

  • KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro

    Joseph H. Chewning;Charlotte N. Gudme;Katharine C. Hsu;Annamalai Selvakumar

  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

    Susan Prockop;Ekaterina Doubrovina;Stephanie Suser;Glenn Heller

  • Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell–depleted allogeneic hematopoietic cell transplantation

    Junli Yu;Jeffrey M. Venstrom;Xiao-Rong Liu;James Pring

  • Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

    Bronwen E. Shaw;Brent R. Logan;Stephen R. Spellman;Steven G.E. Marsh

  • Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

    Jeanette E. Boudreau;Katharine C. Hsu;Katharine C. Hsu

  • HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

    Effie W. Petersdorf;Effie W. Petersdorf;Theodore A. Gooley;Mari Malkki;Andrea P. Bacigalupo

  • KIR and HLA Genotypes are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

    Jeffrey M Venstrom;Junting Zheng;Nabila Noor;Karen E Danis

Frequent Co-Authors

Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin
Richard J. O'Reilly
Richard J. O'Reilly Memorial Sloan Kettering Cancer Center
Michael R. Verneris
Michael R. Verneris University of Colorado Denver
Marcel R.M. van den Brink
Marcel R.M. van den Brink Memorial Sloan Kettering Cancer Center
Nancy A. Kernan
Nancy A. Kernan Memorial Sloan Kettering Cancer Center
Miguel-Angel Perales
Miguel-Angel Perales Memorial Sloan Kettering Cancer Center
Bo Dupont
Bo Dupont Memorial Sloan Kettering Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Bo Dupont
Bo Dupont Kettering University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry offers access to a variety of exciting online degrees and career options in healthcare, life sciences, and management. Many students choose to deepen their expertise through specialized programs that align with their interests and career goals.

For those interested in leadership roles, pursuing an accelerated healthcare management degree online can provide the skills needed for quick entry into administrative positions. Alternatively, if mental health is a passion, consider the fastest pmhnp program to become a specialized nurse practitioner in psychiatric and mental health.

Nutrition is another promising area, with robust nutrition degree programs available for those interested in dietetics or community health. Meanwhile, for aspiring business leaders, the cheapest online mba healthcare programs offer affordable options to gain vital management experience in the healthcare industry.

Whichever path you choose, online degrees provide flexible pathways for Biology and Biochemistry graduates to advance their careers in today’s fast-growing health and science sectors.

Best Scientists Citing Katharine C. Hsu

Trending Scientists

Recently Published Articles